Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FIREFLY NEUROSCIENCE, INC.AIFF · Entity 7759 | Chief Financial Officer | March 10, 2025 | March 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FIREFLY NEUROSCIENCE, INC.
Report date March 10, 2025 · Filed March 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,000 |
Reported balance
After 2025-03-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-03-10 · Grant · Acquired 10,000 · Balance 10,000 F1: On March 10, 2025, the Reporting Person was granted 10,000 restricted stock units under the Issuer's 2024 Long-Term Incentive Plan. The 10,000 restricted stock units vest quarterly over two years commencing on March 10, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. |
| Incentive Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.12 · Expires 2035-03-10 | Direct | 26,024 |
Reported balance
After 2025-03-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-03-10 · Grant · Acquired 15,000 · Balance 26,024 F2: The Incentive Stock Option becomes vested and exercisable over two years in eight equal quarterly installments after the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 10, 2025, the Reporting Person was granted 10,000 restricted stock units under the Issuer's 2024 Long-Term Incentive Plan. The 10,000 restricted stock units vest quarterly over two years commencing on March 10, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
F2: The Incentive Stock Option becomes vested and exercisable over two years in eight equal quarterly installments after the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2025 Filed Mar 12, 2025 22:04 UTC | FIREFLY NEUROSCIENCE, INC. AIFF · Entity 7759 | GrantIncentive Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $3.12 | $0.00 |
DisclosureSEC source: 0001437749-25-007339 · rdgdoc.xml · derivative · entry 2 Krzywicki Paul · CIK 0002037815 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,024 Underlying: Common Stock · 15,000 shares Expires 2035-03-10 F2 · derivative.exercise_date: The Incentive Stock Option becomes vested and exercisable over two years in eight equal quarterly installments after the date of grant. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:04 UTC | FIREFLY NEUROSCIENCE, INC. AIFF · Entity 7759 | GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-007339 · rdgdoc.xml · derivative · entry 1 Krzywicki Paul · CIK 0002037815 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: On March 10, 2025, the Reporting Person was granted 10,000 restricted stock units under the Issuer's 2024 Long-Term Incentive Plan. The 10,000 restricted stock units vest quarterly over two years commencing on March 10, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F1 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted 10,000 restricted stock units under the Issuer's 2024 Long-Term Incentive Plan. The 10,000 restricted stock units vest quarterly over two years commencing on March 10, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F1 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted 10,000 restricted stock units under the Issuer's 2024 Long-Term Incentive Plan. The 10,000 restricted stock units vest quarterly over two years commencing on March 10, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.